Immediate Impact
1 by Nobel laureates 6 from Science/Nature 70 standout
Citing Papers
Transferrin receptor targeting chimeras for membrane protein degradation
2024 StandoutNature
Natural killer cell therapies
2024 StandoutNature
Works of Matthew J. Barth being referenced
Obinutuzumab (GA101) compared to rituximab significantly enhances cell death and antibody-dependent cytotoxicity and improves overall survival against CD20+ rituximab-sensitive/-resistant Burkitt lymphoma (BL) and precursor B-acute lymphoblastic leukaemia
2015
Ofatumumab (OFA) Is a Novel Anti-CD20 Monoclonal Antibody (mAb) with Improved Anti-Tumor Activity in Vitro and in Vivo in Mantle Cell Lymphoma (MCL) Pre-Clinical Models.
2012
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Matthew J. Barth | 360 | 540 | 166 | 374 | 70 | 1.2k | |
| Rosaria De Filippi | 443 | 455 | 284 | 376 | 61 | 1.1k | |
| Friederike Kreisel | 358 | 378 | 202 | 360 | 61 | 1.4k | |
| K. Henry | 349 | 298 | 359 | 279 | 41 | 1.3k | |
| Monika Prochorec‐Sobieszek | 307 | 286 | 166 | 227 | 104 | 1.1k | |
| E. L. Jones | 384 | 301 | 106 | 193 | 81 | 1.2k | |
| Jerald Z. Gong | 492 | 397 | 371 | 259 | 74 | 1.3k | |
| Adriana García‐Herrera | 624 | 587 | 96 | 294 | 103 | 1.4k | |
| Odile David | 206 | 409 | 65 | 349 | 50 | 1.3k | |
| Juehua Gao | 318 | 250 | 264 | 226 | 59 | 1.1k | |
| Csaba Bödör | 358 | 325 | 359 | 351 | 105 | 1.2k |
All Works
Login with ORCID to disown or claim papers
Loading papers...